Team
Information Box Group
Sarah Alrasheed
Clinical Fellow
2023-2024
Sarah Alrasheed
Clinical Fellow
2023-2024
Anastasia Chouvalov
RN, MSc
Patient Care and Research Coordinator
Anastasia Chouvalov
RN, MSc
Patient Care and Research Coordinator
Jenielle Findlater
Administrative Assistant
Jenielle Findlater
Administrative Assistant
Andrea Gardner
RN BSN
Clinical Nurse Coordinator
Research Coordinator
Andrea Gardner
RN BSN
Clinical Nurse Coordinator
Research Coordinator
Nathan Hambly
Associate Professor
Department of Medicine
- Pulmonary hypertension
- Interstitial lung disease
- Sarcoidosis and acute exacerbations of idiopathic pulmonary fibrosis
Moaaz Rashad
Clinical Fellow
2023-2024
Moaaz Rashad
Clinical Fellow
2023-2024
Sarah Alrasheed
Clinical Fellow
2023-2024
Sarah Alrasheed
Clinical Fellow
2023-2024
Anastasia Chouvalov
RN, MSc
Patient Care and Research Coordinator
Anastasia Chouvalov
RN, MSc
Patient Care and Research Coordinator
Jenielle Findlater
Administrative Assistant
Jenielle Findlater
Administrative Assistant
Andrea Gardner
RN BSN
Clinical Nurse Coordinator
Research Coordinator
Andrea Gardner
RN BSN
Clinical Nurse Coordinator
Research Coordinator
Nathan Hambly
Associate Professor
Department of Medicine
- Pulmonary hypertension
- Interstitial lung disease
- Sarcoidosis and acute exacerbations of idiopathic pulmonary fibrosis
Nathan Hambly
Associate Professor
Department of Medicine
- Pulmonary hypertension
- Interstitial lung disease
- Sarcoidosis and acute exacerbations of idiopathic pulmonary fibrosis
Moaaz Rashad
Clinical Fellow
2023-2024
Moaaz Rashad
Clinical Fellow
2023-2024
PH Program
PH Research
- HYPERION (A011-13)
- Title: Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients
- Disease group: PH
- Principal Investigator: Dr. Nathan Hambly
- Sponsor: Acceleron Pharma Inc.; Merck & Co. Inc.
- Link: Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13) – Full Text View – ClinicalTrials.gov
- Status: Active, recruiting
- UNISUS (ACC-055-315)
- Title: A Phase 3, Prospective, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel-group, Group-sequential, Adaptive, Event-driven Study to Compare Efficacy, Safety, and Tolerability of Macitentan 75 mg Versus Macitentan 10 mg in Patients With Pulmonary Arterial Hypertension, Followed by an Open-label Treatment Period With Macitentan 75 mg
- Disease group: PAH
- Principal Investigator: Dr. Nathan Hambly
- Sponsor: Actelion Pharmaceuticals Ltd.; Janssen Pharmaceuticals
- Link: Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension – Full Text View – ClinicalTrials.gov
- Status: Active, recruiting
Canadian Pulmonary Hypertension Registry (CPHR) – https://phacanada.ca/Research/Canadian-PH-Registry
For more information regarding pulmonary hypertension research opportunities, please contact PH Research Nurse Coordinator Andrea Gardner at 905-522-1155 ext. 33626
Pulmonary Arterial Hypertension Fellowship
The McMaster University PH Program at St. Joseph’s Health Healthcare is a Nationally Recognized site of PH excellence. We review approximately 125 consultations annually and manage a prevalent population of 150 patients with Group 1 PAH and CTEPH. Given our location within the Firestone Institute for Respiratory Health, the emphasis is also applied to the evaluation and management of Group 3 PH and sarcoid-related PH. Focus is applied to both clinical excellence and the application of the clinical experience to innovative research projects utilizing both local and national registry data.
Further information regarding the ILD fellowship program can be found at: https://medicine.healthsci.mcmaster.ca/divisions/respirology/respirology-education/respirology-interstitial-lung-disease-fellowship/
PH Patient Education
Navigation Groups
-
Medication Information
Learn more about the medications you may be prescribed
-
Testing Information
You may be scheduled for a specific procedure during your visit
-
Patient Resources
Materials you may find beneficial, including Podcasts, videos, ect.